Skip to main content
Figure 7 | BMC Biology

Figure 7

From: Receptor oligomerization and beyond: a case study in bone morphogenetic proteins

Figure 7

Inhibition of the SMAD and p38 mitogen-activated protein (MAP) kinase pathway. Alkaline phosphatase (ALP) assays were carried out using C2C12 cells in the absence or presence of 250 nM of bone morphogenic protein (wild type) (BMP2wt). (a) Dorsomorphin (DM) or (b) SB203580 was added at the indicated timepoints. The background absorption at 405 nm of 0.09 ± 0.0075 was not subtracted to indicate the signal to noise ratio.

Back to article page